Showing results (631-640 of 3,491) with videos related to
Sort By:
Pageof 350
Archiv Der Pharmazie|January 3, 2018
Design, synthesis, and pharmacological evaluation of fluorinated azoles as anti-tubercular agentsSomnath Gholap, Macchindra Tambe, Laxman Nawale, et al.Archiv Der Pharmazie|September 7, 2020
Novel 1,2,4-triazole derivatives: Design, synthesis, anticancer evaluation, molecular docking, and pharmacokinetic profiling studiesAbdallah Turky, Farag F Sherbiny, Ashraf H Bayoumi, et al.Archiv Der Pharmazie|January 8, 2023
Pyrazole scaffold-based derivatives: A glimpse of α-glucosidase inhibitory activity, SAR, and route of synthesisJannat Ul Firdaus, Nadeem Siddiqui, Ozair Alam, et al.Archiv Der Pharmazie|December 26, 2022
Artemisinin-isatin hybrids tethered via ethylene linker and their anti-lung cancer activityRuo Wang, Qianru Zhang, Min ChenArchiv Der Pharmazie|June 2, 2021
Purification of a novel protein with cytotoxicity against non-small-cell lung cancer cells from Boletus bicolorMin-Hui Zhang, Rong Zhou, Fang Liu, et al.Archiv Der Pharmazie|June 1, 2022
Insights into modulating the monastrol scaffold: Development of new pyrimidinones as Eg5 inhibitors with anticancer activityMohamed G Thabit, Amany S Mostafa, Khalid B Selim, et al.Archiv Der Pharmazie|November 28, 2022
New chimeric HDAC inhibitors for the treatment of colorectal cancerSofia I Bär, Rohan Pradhan, Bernhard Biersack, et al.Archiv Der Pharmazie|December 3, 2022
Synthesis, antimycobacterial, cytotoxicity, anti-inflammatory, in silico studies and molecular dynamics of pyrazole-embedded thiazolidin-4-one hybridsVinuta Kamat, Boja Poojary, Divyaraj Puthran, et al.Archiv Der Pharmazie|June 6, 2022
Hybrid imidazo[1,2-a]pyridine analogs as potent ATX inhibitors with concrete in vivo antifibrosis effectTong Li, Hongrui Lei, Juanjuan Yang, et al.Pageof 350